A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury

Kuba, Keiji, Imai, Yumiko, Rao, Shuan, Gao, Hong, Guo, Feng, Guan, Bin, Huan, Yi, Yang, Peng +16 more·2005·Nature Medicine
DOI 10.1038/nm1267

Cited by (1,008)

Items 601–700 of 1,008

  1. Is Antioxidant Therapy a Useful Complementary Measure for Covid-19 Treatment? An Algorithm for Its Application
    Marí­a Elena Soto, Verónica Guarner‐Lans, Elizabeth Soria‐Castro, Linaloe Manzano Pech, Israel Pérez-Torres · 2020 · Medicina
  2. Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients
    Espen Jimenez‐Solem, Tonny Studsgaard Petersen, Casper Hansen, Christian Hansen, Christina Lioma, Christian Igel, Wouter Boomsma, Oswin Krause, Stephan Sloth Lorenzen, Raghavendra Selvan et al. · 2021 · Scientific Reports
  3. Increased Angiotensin-Converting Enzyme 2 and Loss of Alveolar Type II Cells in COVID-19–related Acute Respiratory Distress Syndrome
    Ludovic Gérard, Marylène Lecocq, Caroline Bouzin, Delphine Hoton, Gregory Schmit, João Pinto Pereira, Virginie Montiel, Thomas Planté-Bordeneuve, Pierre‐François Laterre, Charles Pilette · 2021 · American Journal of Respiratory and Critical Care Medicine
  4. The renin angiotensin aldosterone system
    Hannah Triebel, Hayo Castrop · 2024 · Pflügers Archiv - European Journal of Physiology
  5. Interaction of severe acute respiratory syndrome-coronavirus and NL63 coronavirus spike proteins with angiotensin converting enzyme-2
    Alison C. Mathewson, Alexandra Bishop, Yongxiu Yao, Fred Kemp, Junyuan Ren, Hongying Chen, Xiaodong Xu, Ben Berkhout, Lia van der Hoek, Ian Martin Jones · 2008 · Journal of General Virology
  6. Coronavirus Disease 2019 (COVID-19) and its implications for cardiovascular care: expert document from the German Cardiac Society and the World Heart Federation
    Michael Böhm, Norbert Frey, Evangelos Giannitsis, Karen S Sliwa, Andreas Michael Zeiher · 2020 · Clinical Research in Cardiology
  7. COVID-19 in Human, Animal, and Environment: A Review
    Ayman A. Swelum, Manal Esam Shafi, Najah M. Albaqami, Mohamed T. El‐Saadony, Ahmed Mahmoud Elsify, Mohamed Abdo, Ayman El-sayed Taha, Abdel‐Moneim Eid Abdel‐Moneim, Naif Ahmed Al-Gabri, Amer A. Almaiman et al. · 2020 · Frontiers in Veterinary Science
  8. Manipulation of ACE2 expression in COVID-19
    Farhan Chaudhry, Sergio Lavandero, Xiang Xie, Basera Sabharwal, Ying‐Ying Zheng, Ashish Adrian Correa, Jagat Narula, Phillip David Levy · 2020 · Open Heart
  9. ACE2 expression is elevated in airway epithelial cells from older and male healthy individuals but reduced in asthma
    Peter A. B. Wark, Prabuddha S. Pathinayake, Gerard E. Kaiko, Kristy Nichol, Ayesha Ali, Ling Chen, Erika N. Sutanto, Luke W. Garratt, Sukhwinder Singh Sohal, Wenying Lu et al. · 2021 · Respirology
  10. Potential Natural Products Against Respiratory Viruses: A Perspective to Develop Anti-COVID-19 Medicines
    Marzieh Omrani, Mohsen Keshavarz, Samad Nejad Ebrahimi, Meysam Mehrabi, Lyndy Joy McGaw, Muna Ali Abdalla, Parvaneh Mehrbod · 2021 · Frontiers in Pharmacology
  11. The Pathogenicity of SARS-CoV-2 in hACE2 Transgenic Mice
    Linlin Bao, Wei Deng, Baoying Huang, Hong Gao, Jiangning Liu, Lili Ren, Qiang Wei, Pin Yu, Yanfeng Xu, Feifei Qi et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  12. Kinins and Cytokines in COVID-19: A Comprehensive Pathophysiological Approach
    Frank L. van de Veerdonk, Mihai Gheorghe Netea, Marcel van Deuren, Jos W. M. van der Meer, Quirijn de Mast, Roger J. M. Brüggemann, Hans van der Hoeven · 2020 · Preprints.org
  13. Epidemiologic and clinical characteristics of heart transplant recipients during the 2019 coronavirus outbreak in Wuhan, China: A descriptive survey report
    Zongli Ren, Rui Hu, Zhiwei Wang, Min Zhang, Yongle Ruan, Zhiyong Wu, Hongbing Wu, Xiao-Ping Hu, Zhipeng Hu, Wei Ren et al. · 2020 · The Journal of Heart and Lung Transplantation
  14. Advances in the relationship between coronavirus infection and cardiovascular diseases
    Mengmeng Zhao, Menglong Wang, Jishou Zhang, Jing Ye, Yao Qun Xu, Zhen Wang, Di Ye, Jianfang Liu, Jun Wan · 2020 · Biomedicine & Pharmacotherapy
  15. Targeting SARS-CoV-2 receptors as a means for reducing infectivity and improving antiviral and immune response: an algorithm-based method for overcoming resistance to antiviral agents
    Ram Gelman, Areej Bayatra, Asa Kessler, Asaf Schwartz, Yaron Ilan · 2020 · Emerging Microbes & Infections
  16. COVID-19 and cardiovascular diseases
    Francesca Mai, Rita Del Pinto, Claudio Ferri · 2020 · Journal of Cardiology
  17. Angiotensin-Converting Enzyme Gene Polymorphism and Severe Lung Injury in Patients with Coronavirus Disease 2019
    Haoyi Zheng, J. Jane Cao · 2020 · American Journal Of Pathology
  18. Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries
    Kaiming Wang, Mahmoud Gheblawi, Anish Nikhanj, Matthew Munan, Erika MacIntyre, Conar O’Neil, Marko Poglitsch, Daniele Colombo, Franca Del Nonno, Zamaneh Kassiri et al. · 2021 · Hypertension
  19. Good ACE, bad ACE do battle in lung injury, SARS
    John Malcolm Nicholls, Malik J. S. Peiris · 2005 · Nature Medicine
  20. Potential new treatment strategies for COVID-19: is there a role for bromhexine as add-on therapy?
    Markus Depfenhart, Danielle de Villiers, Gottfried H. Lemperle, Markus Meyer, Salvatore Di Somma · 2020 · Internal and Emergency Medicine
  21. O Efeito da Doença de Coronavírus 2019 nas Doenças Cardiovasculares
    Lütfü Aşkın, Okan Tanrıverdi, Hüsna Şengül Aşkın · 2020 · Arquivos Brasileiros de Cardiologia
  22. Implications for Neuromodulation Therapy to Control Inflammation and Related Organ Dysfunction in COVID-19
    Marat Fudim, Yawar Jamal Qadri, Kamrouz Ghadimi, David B. MacLeod, Jeroen Molinger, Jonathan Paul Piccini, John Whittle, Paul Edmund Wischmeyer, Manesh R. Patel, Luis Ulloa · 2020 · Journal of Cardiovascular Translational Research
  23. Potential Targets for Treatment of Coronavirus Disease 2019 (COVID-19): A Review of Qing-Fei-Pai-Du-Tang and Its Major Herbs
    Linda L. D. Zhong, Wai Ching Lam, Wei Yang, Kam Wa Chan, Stephen Cho Wing Sze, Jiangxia Miao, Ken Kin Lam Yung, Zhaoxiang Bian, Vivian Taam Wong · 2020 · The American Journal of Chinese Medicine
  24. Severe COVID-19: what have we learned with the immunopathogenesis?
    Bruno Bordallo Corrêa, Mozart Bellas Rodrigues, Arthur Fernandes Cortez, Matheus Vieira, Marcelo M. Pinheiro · 2020 · Revista Brasileira de Reumatologia
  25. Renin–Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress Syndrome
    Jaroslav Hrenak, Fedor Šimko · 2020 · International Journal of Molecular Sciences
  26. Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
    André Feldman, Guilherme D’andrea Saba Arruda, Olga Ferreira de Souza · 2020 · Journal of Cardiac Arrhythmias
  27. Implications of SARS‐CoV‐2 infection for neurogastroenterology
    Giovanni Marasco, Marco Vincenzo Lenti, Cesare Cremon, Maria Raffaella Barbaro, Vincenzo Stanghellini, Antonio Di Sabatino, Giovanni Barbara · 2021 · Neurogastroenterology & Motility
  28. Hematopoietic responses to SARS-CoV-2 infection
    Shokrollah Elahi · 2022 · Cellular and Molecular Life Sciences
  29. SARS-CoV-2 and SARS-CoV Spike-RBD Structure and Receptor Binding Comparison and Potential Implications on Neutralizing Antibody and Vaccine Development
    Chunyun Sun, Long Chen, Ji Yang, Chunxia Luo, Yanjing Zhang, Jing Li, Jiahui Yang, Jie Zhang, Liangzhi Xie · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  30. Computational Prediction of Mutational Effects on SARS-CoV‑2 Binding by Relative Free Energy Calculations
    Junjie Zou, Jian Yin, Lei Fang, Mingjun Yang, Tianyuan Wang, Weikun Wu, Michael A. Bellucci, Peiyu Zhang · 2020 · Journal of Chemical Information and Modeling
  31. Diabetes and COVID-19: Global and regional perspectives
    In‐Kyung Jeong, Kun‐Ho Yoon, Moon Kyu Lee · 2020 · Diabetes Research and Clinical Practice
  32. Potential role of ACE2-related microRNAs in COVID-19-associated nephropathy
    Ahmedz Widiasta, Yunia Sribudiani, Husna Nugrahapraja, Dany Hilmanto, Nanan Sekarwana, Dedi Rachmadi · 2020 · Non-coding RNA Research
  33. Endothelial cells and SARS-CoV-2: An intimate relationship
    Lucas Cunha Barbosa, Thaynan Lopes Gonçalves, Luanna Prudencio de Araújo, Luciane Rosário, Valéria Pereira Ferrer · 2021 · Vascular Pharmacology
  34. Severe COVID-19 Lung Infection in Older People and Periodontitis
    Rubén Aquino-Martínez, Scarlette Hernández Vigueras · 2021 · Journal of Clinical Medicine
  35. Will curcumin nanosystems be the next promising antiviral alternatives in COVID-19 treatment trials?
    Douglas Dourado, Danielle Teixeira Freire, Daniel Torres Pereira, Lucas Amaral-Machado, Éverton do Nascimento Alencar, André Luís Branco de Barros, Eryvaldo Sócrates Tabosa do Egito · 2021 · Biomedicine & Pharmacotherapy
  36. ACE2 expression in rat brain: Implications for COVID-19 associated neurological manifestations
    Vito S. Hernández, Mario A. Zetter, Enrique C. Guerra, Ileana Hernández‐Araiza, Nikita Karuzin, Oscar R. Hernández‐Pérez, Lee E. Eiden, Limei Zhang · 2021 · Experimental Neurology
  37. COVID-19 Disease and Ophthalmology: An Update
    Virginia Amesty, Jorge L. Alió del Barrio, JORGE LUCIANO ALIO · 2020 · Ophthalmology and Therapy
  38. COVID-19
    Paolo Verdecchia, Claudio Cavallini, Antonio Spanevello, Fabio Angeli · 2020 · Hypertension
  39. COVID-19 and the renin-angiotensin system (RAS): A spark that sets the forest alight?
    Owen J Wiese, Brian Allwood, Annalise E. Zemlin · 2020 · Medical Hypotheses
  40. Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19
    Tarek Mohamed Abd El‐Aziz, Ahmed Al-Sabi, James D. Stockand · 2020 · Signal Transduction and Targeted Therapy
  41. SARS-CoV-2 Infection in the Central and Peripheral Nervous System-Associated Morbidities and Their Potential Mechanism
    Mohan Kumar Muthu Karuppan, Dinesh Devadoss, Madhavan G. Nair, Hitendra Singh Chand, Madepalli Krishnappa Lakshmana · 2021 · Molecular Neurobiology
  42. Oral Symptoms Associated with COVID-19 and Their Pathogenic Mechanisms: A Literature Review
    Hironori Tsuchiya · 2021 · Dentistry Journal
  43. SARS-CoV-2 colonization of maternal and fetal cells of the human placenta promotes alteration of local renin-angiotensin system
    Sonam Verma, Chetanchandra S. Joshi, Rachel B. Silverstein, Mai He, Ebony Boyce Carter, Indira U. Mysorekar · 2021 · Med
  44. COVID-19 and Hypertension: The What, the Why, and the How
    Shah-Abas Muhamad, Azizah Ugusman, Jaya Kumar, Dominik S. Skiba, Adila A. Hamid, Amilia Aminuddin · 2021 · Frontiers in Physiology
  45. Cardiovascular disease and <scp>COVID</scp> ‐19: Australian and New Zealand consensus statement
    Zaman, Sarah, MacIsaac, Andrew I, Jennings, Garry LR, Schlaich, Markus P, Inglis, Sally C, Arnold, Ruth, Kumar, Saurabh, Thomas, Liza, Wahi, Sudhir, Lo, Sidney et al. · 2020 · Medical Journal of Australia
  46. Increased blood angiotensin converting enzyme 2 activity in critically ill COVID-19 patients
    van Lier, Dirk, Kox, Matthijs, Santos, Karine, van der Hoeven, Hans, Pillay, Janesh, Pickkers, Peter · 2021 · ERJ Open Research
  47. Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives
    Μaria Dalamaga, Gerasimos Socrates Christodoulatos, Ιrene Karampela, Natalia G. Vallianou, Caroline Margaret Apovian · 2021 · Current Obesity Reports
  48. The Renin-Angiotensin System: A Key Role in SARS-CoV-2-Induced COVID-19
    George El-Arif, Antonella Farhat, Shaymaa Khazaal, C. Annweiler, Hervé Kovacic, Ying-Liang Wu, Zhi-Jian Cao, Z. Fajloun, Ziad Abi Khattar, J. Sabatier · 2021 · Molecules
  49. Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease
    María Sabater Molina, Elisa Nicolás Rocamora, Asunción Iborra Bendicho, E. G. Vázquez, E. Zorio, F. D. Rodriguez, Cristina Gil Ortuño, A. I. Rodríguez, A. Sánchez-López, Rubén Jara Rubio et al. · 2022 · PLoS ONE
  50. Identification of residues in the receptor-binding domain (RBD) of the spike protein of human coronavirus NL63 that are critical for the RBD–ACE2 receptor interaction
    Han-Xin Lin, Yan Feng, Gillian Wong, Liping Wang, Bei Li, Xuesen Zhao, Yan Li, Fiona Smaill, Chengsheng Zhang · 2008 · Journal of General Virology
  51. Coronavirus and Obesity: Could Insulin Resistance Mediate the Severity of Covid-19 Infection?
    Francis Martin Finucane, Colin Davenport · 2020 · Frontiers in Public Health
  52. Sex-derived attributes contributing to SARS-CoV-2 mortality
    Neha Chanana, Tsering Palmo, Kavita Sharma, Rahul Kumar, Brian B. Graham, Qadar Pasha · 2020 · American Journal of Physiology-Endocrinology and Metabolism
  53. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development
    Sana O. Alturki, Sawsan O. Alturki, Jennifer R Connors, Gina M. Cusimano, Michele A. Kutzler, Abdullah M. Izmirly, Elias K. Haddad · 2020 · Frontiers in Immunology
  54. Subacute Thyroiditis from COVID-19 Infection: A Case Report and Review of Literature
    Akshay M Khatri, Esti Charlap, Angela Kim · 2020 · European Thyroid Journal
  55. The other side of COVID‐19 pandemic: Effects on male fertility
    Cemile Merve Seymen · 2020 · Journal of Medical Virology
  56. Transport of Amino Acids in the Kidney
    Victoria Makrides, Simone M. R. Camargo, François Verrey · 2014 · Comprehensive physiology
  57. [Pyr1]Apelin-13(1–12) Is a Biologically Active ACE2 Metabolite of the Endogenous Cardiovascular Peptide [Pyr1]Apelin-13
    Peiran B Yang, Rhoda E. Kuc, Aimée Brame, Alex Dyson, Mervyn Singer, Robert Charles Glen, Joseph Cheriyan, Ian B. Wilkinson, Anthony P. Davenport, Janet J. Maguire · 2017 · Frontiers in Neuroscience
  58. SARS-CoV-2 and diabetes: New challenges for the disease
    Cecília Cristelo, Cláudia Azevedo, Joana Moreira Marques, Rute Nunes, Bruno Filipe Carmelino Cardoso Sarmento · 2020 · Diabetes Research and Clinical Practice
  59. An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2
    Takuya Tada, Chen Fan, Jennifer Chen, Ramanjit Kaur, Kenneth A. Stapleford, Harry B. Gristick, Belinda M. Dcosta, Craig B. Wilen, Crina M. Nimigean, Nathaniel Roy Landau · 2020 · Cell Reports
  60. Soluble angiotensin‐converting enzyme 2 is transiently elevated in COVID‐19 and correlates with specific inflammatory and endothelial markers
    Annika Lundström, Louise Ziegler, Sebastian Havervall, Ann‐Sofie Rudberg, Fien A. von Meijenfeldt, Ton Lisman, Nigel Mackman, Per Sandén, Charlotte Thålin · 2021 · Journal of Medical Virology
  61. SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages
    Ioanna Pantazi, Ahmed Ali Al-Qahtani, Fatimah S. Alhamlan, Hani Alothaid, Sabine Matou‐Nasri, George Sourvinos, Eleni Vergadi, Christos Tsatsanis · 2021 · Frontiers in Immunology
  62. Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty
    Paul P. Cheng, Han Zhu, Ronald M. Witteles, Joseph C. Wu, Thomas Quertermous, Sean M. Wu, June‐Wha Rhee · 2020 · Current Cardiology Reports
  63. Molecular Insights Into SARS COV-2 Interaction With Cardiovascular Disease: Role of RAAS and MAPK Signaling
    Zena Wehbe, Safaa H. Hammoud, Nadia Soudani, Hassan Zaraket, Ahmed Fawzy EL‐Yazbi, Ali Hussein Eid · 2020 · Frontiers in Pharmacology
  64. Can phytotherapy with polyphenols serve as a powerful approach for the prevention and therapy tool of novel coronavirus disease 2019 (COVID-19)?
    Emile H. Levy, EDGARD E. DELVIN, Valérie Marcil, Schohraya Spahis · 2020 · American Journal of Physiology-Endocrinology and Metabolism
  65. ACE2, COVID-19 Infection, Inflammation, and Coagulopathy: Missing Pieces in the Puzzle
    Zaid A. Abassi, Abd Al‐Roof Higazi, Safa Kinaneh, Zaher Armaly, Karl L. Skorecki, Samuel Noam Heyman · 2020 · Frontiers in Physiology
  66. SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Host Cells: Implications for Possible Consequences of COVID-19 Vaccines
    Yuichiro Suzuki, Sergiy G. Gychka · 2021 · Vaccines
  67. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update
    Ashwin Kumar Shukla, Monisha Banerjee · 2021 · High Blood Pressure & Cardiovascular Prevention
  68. Coronavirus Disease-2019 (COVID-19) and Cardiovascular Complications
    Lulu Ma, Kaicheng Song, Yuguang Huang · 2020 · Journal of Cardiothoracic and Vascular Anesthesia
  69. Bibliometric analysis of global scientific research on Coronavirus (COVID-19).
    Hojat Dehghanbanadaki, Farhad Seif, Yasmin Vahidi, Farideh Razi, Ehsan Hashemi, Majid Khoshmirsafa, Hossein Aazami · 2020 · PubMed Central
  70. SARS-CoV-2 disease severity and diabetes: why the connection and what is to be done?
    Caio Henrique Mazucanti, Josephine Mary Egan · 2020 · Immunity & Ageing
  71. ACE deletion allele is associated with susceptibility to SARS-CoV-2 infection and mortality rate: An epidemiological study in the Asian population
    Abhijit Pati, Harishankar Mahto, Sunali Padhi, Aditya K. Panda · 2020 · Clinica Chimica Acta
  72. Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies
    Ting Zhou, Tina Tianjiao Su, Tenny Mudianto, Jun Wang · 2020 · The Journal of Experimental Medicine
  73. COVID-19: Proposing a Ketone-Based Metabolic Therapy as a Treatment to Blunt the Cytokine Storm
    Patrick C. Bradshaw, William A. Seeds, Alexandra C. Miller, Vikrant R. Mahajan, William M. Curtis · 2020 · Oxidative Medicine and Cellular Longevity
  74. Research progress on Mesenchymal Stem Cells (MSCs), Adipose-Derived Mesenchymal Stem Cells (AD-MSCs), Drugs, and Vaccines in Inhibiting COVID-19 Disease
    Pietro Gentile, Aris Sterodimas, Jacopo Pizzicannella, Claudio Calabrese, Simone Garcovich · 2020 · Aging and Disease
  75. Perspective: The Potential Effects of Naringenin in COVID-19
    Ricardo Wesley Alberca, Franciane Mouradian Emidio Teixeira, Danielle Rosa Beserra, Emily Araujo de Oliveira, Milena Mary de Souza Andrade, Anna Julia Pietrobon, Maria Notomi Sato · 2020 · Frontiers in Immunology
  76. Prospective options of algae-derived nutraceuticals as supplements to combat COVID-19 and human coronavirus diseases
    Sachitra Kumar Ratha, Nirmal Renuka, Ismail Rawat, Faizal Bux · 2020 · Nutrition
  77. Incidence, clinical features, and outcomes of COVID-19 in Canada: impact of sex and age
    Jacob Anderson O’Brien, Kevin Y. Du, Chun Peng · 2020 · Journal of Ovarian Research
  78. Kidney injury molecule-1 is a potential receptor for SARS-CoV-2
    Chen Yang, Yu Long Zhang, Xia Zeng, Huijing Chen, Yuchen Chen, Dong Yang, Ziwei Shen, Xiaomu Wang, Xinran Liu, Mingrui Xiong et al. · 2021 · Journal of Molecular Cell Biology
  79. Interplay Among the Oral Microbiome, Oral Cavity Conditions, the Host Immune Response, Diabetes Mellitus, and Its Associated-Risk Factors—An Overview
    Thaís de Cássia Negrini, Iracilda Zeppone Carlos, Cristiane Duque, Karina Sampaio Caiaffa, Rodrigo Alex Arthur · 2021 · Frontiers in Oral Health
  80. A scoping review of the pathophysiology of COVID-19
    Paul Ellis Marik, Jose I. Iglesias, Joseph Varón, Pierre D. Kory · 2021 · International Journal of Immunopathology and Pharmacology
  81. Potential mechanisms of hemorrhagic stroke in elderly COVID-19 patients
    Wang, Haili, Tang, Xiaojia, Fan, Hongyang, Luo, Yuhan, Song, Yuxia, Xu, Yao, Chen, Yingzhu · 2020 · Aging
  82. A Review on SARS-CoV-2 Virology, Pathophysiology, Animal Models, and Anti-Viral Interventions
    Sabari Nath Neerukonda, Upendra Katneni · 2020 · Pathogens
  83. Let’s talk about sex in the context of COVID-19
    Luciane H. Gargaglioni, Danuzia Ambrozio Marques · 2020 · Journal of Applied Physiology
  84. Proper Management of People with Obesity during the COVID-19 Pandemic
    Soo Kyung Lim, Soo Myoung Shin, Ga Eun Nam, Chang Hee Jung, Bo Kyung Koo · 2020 · Journal of Obesity & Metabolic Syndrome
  85. ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases
    Ravindra Kumar Sharma, Bruce R. Stevens, Alexander G. Obukhov, Maria B. Grant, Gavin Y. Oudit, Qiuhong Li, Elaine M. Richards, Carl J. Pepine, Mohan K. Raizada · 2020 · Hypertension
  86. Expression of ACE2, the SARS-CoV-2 Receptor, in Lung Tissue of Patients With Type 2 Diabetes
    Sara Renata Alex Wijnant, Merel Jacobs, Hannelore P. Van Eeckhoutte, Bruno Lapauw, Guy Joos, Ken R. Bracke, Guy Brusselle, Guy Brusselle · 2020 · Diabetes
  87. Renal Injury by SARS-CoV-2 Infection: A Systematic Review
    Mo Wang, Hua-Ying Xiong, Han Chen, Qiu Li, Xiong Zhong Ruan · 2020 · Kidney Diseases
  88. ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker
    Yuning Chen, Yanan Zhang, Renhong Yan, Guifeng Wang, Yuanyuan Zhang, Zherui Zhang, Yaning Li, Jianxia Ou, Wendi Chu, Zhijuan Liang et al. · 2021 · Signal Transduction and Targeted Therapy
  89. Vitamin D and COVID-19: An Overview of Recent Evidence
    Drishti P. Ghelani, Simon Alesi, Aya Mousa · 2021 · International Journal of Molecular Sciences
  90. SARS-CoV-2: Emerging Role in the Pathogenesis of Various Thyroid Diseases
    Avaniyapuram Kannan Murugan, Ali Saeed Alzahrani · 2021 · Journal of Inflammation Research
  91. The tissue renin–angiotensin system and intracellular signalling
    Ingrid Fleming, Karin Kohlstedt, Rudi Busse · 2005 · Current Opinion in Nephrology & Hypertension
  92. The Tissue Renin-Angiotensin System and Its Role in the Pathogenesis of Major Human Diseases: Quo Vadis?
    Babak Saravi, Zhen Li, Corinna N. Lang, Bonaventura Schmid, Frauke K. Lang, Sibylle Grad, Mauro Alini, Robert Geoff Richards, Hagen Schmal, Norbert Paul Südkamp et al. · 2021 · Cells
  93. Randomized double-blind placebo-controlled proof-of-concept trial of resveratrol for outpatient treatment of mild coronavirus disease (COVID-19)
    Marvin R. McCreary, Patrick Schnell, Dale A. Rhoda · 2022 · Scientific Reports
  94. Selective and specific regulation of ectodomain shedding of angiotensin-converting enzyme 2 by tumor necrosis factor α-converting enzyme
    Michikado Iwata, Jorge Silva Enciso, Barry Greenberg · 2009 · American Journal of Physiology-Cell Physiology
  95. Expression and regulation of the neutral amino acid transporter B0AT1 in rat small intestine
    Julia Jando, Simone M. R. Camargo, Brigitte Herzog, François Verrey · 2017 · PLoS ONE
  96. Biological plausibility for interactions between dietary fat, resveratrol, ACE2, and SARS-CoV illness severity
    Justine R. Horne, Marie‐Claude Vohl · 2020 · American Journal of Physiology-Endocrinology and Metabolism
  97. An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants
    Shiho Tanaka, Gard Nelson, C. Anders Olson, Oleksandr V. Buzko, Wendy Higashide, Annie Shin, Marcos R. Gonzalez, Justin D. Taft, Roosheel S. Patel, Sofija Buta et al. · 2021 · Scientific Reports
  98. Role of the Renin–Angiotensin–Aldosterone and Kinin–Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID
    Samantha Louise Cooper, Eleanor Boyle, Sophie R. Jefferson, Calum Heslop, Pirathini Mohan, Gearry G. J. Mohanraj, Hamza A. Sidow, Rory C. P. Tan, Stephen John Hill, Jeanette Woolard · 2021 · International Journal of Molecular Sciences
  99. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19
    Keiji Kuba, Tomokazu Yamaguchi, Josef Martin Penninger · 2021 · Frontiers in Immunology
  100. Influence of COVID-19 on Cerebrovascular Disease and its Possible Mechanism
    Hongyang Fan, Xiaojia Tang, Yuxia Song, Peipei Liu, Yingzhu Chen · 2020 · Neuropsychiatric Disease and Treatment